| The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial) (NCT05419089) | Icahn School of Medicine at Mount Sinai | 2022-07-12 |
| Evaluate the Effect of ReSpace™ Hydrogel on Reducing Rectal Radiation Dose in Radiotherapy for Cervical Cancer (NCT05690906) | Peking Union Medical College Hospital | 2022-07-12 |
| A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure (NCT05451329) | VivaVision Biotech, Inc | 2022-07-12 |
| An Innovative Chinese Herbal Formula for Macular Edema (NCT05122702) | Chinese University of Hong Kong | 2022-07-12 |
| ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study (NCT05481827) | Gyroscope Therapeutics Limited | 2022-07-12 |
| An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome (NCT05011851) | Neuren Pharmaceuticals Limited | 2022-07-12 |
| A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001) (NCT05353647) | David Williams | 2022-07-12 |
| A Study to Evaluate the Efficacy of PanCytoVir™ for the Treatment of Non-Hospitalized Patients With COVID-19 Infection (NCT05442983) | TrippBio, Inc. | 2022-07-12 |
| A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1) (NCT05487170) | Ranok Therapeutics (Hangzhou) Co., Ltd. | 2022-07-12 |
| Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage (NCT05554211) | Northwestern University | 2022-07-12 |
| A Study of NTX-001 in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair. (NCT05293522) | Neuraptive Therapeutics Inc. | 2022-07-12 |
| A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL) (NCT05460533) | Memorial Sloan Kettering Cancer Center | 2022-07-12 |
| Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy (NCT05435313) | Fudan University | 2022-07-12 |
| Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis (NCT05511519) | Aclaris Therapeutics, Inc. | 2022-07-12 |
| A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps (NCT05324137) | Keymed Biosciences Co.Ltd | 2022-07-11 |
| A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02) (NCT05460273) | AstraZeneca | 2022-07-11 |
| Topical Ruxolitinib in Chronic Hand Dermatitis (NCT05293717) | University of Rochester | 2022-07-11 |
| Phase 1/2 Study of CAN103 in Subjects With Gaucher Disease (NCT05447494) | CANbridge (Suzhou) Bio-pharma Co., Ltd. | 2022-07-11 |
| Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer (NCT05288777) | University of Virginia | 2022-07-11 |
| Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS) (NCT05469464) | UNION therapeutics | 2022-07-11 |
| Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients. (NCT04915248) | Fondazione Italiana Linfomi - ETS | 2022-07-11 |
| Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE) (NCT05465343) | Peking Union Medical College | 2022-07-11 |
| A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer (NCT05217446) | Pfizer | 2022-07-11 |
| Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking (NCT05181891) | Washington State University | 2022-07-11 |
| Niraparib Efficacy in Patient With Unresectable Mesothelioma (NCT05455424) | University Hospital Southampton NHS Foundation Trust | 2022-07-11 |
| Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster (NCT05463354) | WestVac Biopharma Co., Ltd. | 2022-07-11 |
| Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial (NCT05142241) | National Cancer Institute (NCI) | 2022-07-11 |
| Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY) (NCT05148715) | Université de Sherbrooke | 2022-07-11 |
| OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer (NCT05232136) | Binhui Biopharmaceutical Co., Ltd. | 2022-07-11 |
| The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment (NCT05458284) | Memorial Sloan Kettering Cancer Center | 2022-07-11 |
| A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung Cancer (NCT05431569) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2022-07-10 |
| A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer (NCT05438706) | Fudan University | 2022-07-10 |
| Safety, Tolerability and Efficacy of Nefopam Cream in Burn Patients (NCT04685577) | University of Alberta | 2022-07-10 |
| Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients (NCT05433350) | Drugs for Neglected Diseases | 2022-07-09 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar (NCT05434897) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2022-07-08 |
| Phase II Study of TAEST16001 in Soft Tissue Sarcoma (NCT05549921) | Sun Yat-sen University | 2022-07-08 |
| Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists (NCT05463133) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-07-08 |
| Clinical Recruitment of Patients With First-line Targeted Drug Resistance or Intolerance to Hepatocellular Cancer With PD-1 Inhibitor (Toripalimab,JS001) Detected on the NGS Platform Combined With Anlotinib (NCT05453383) | Shen Feng | 2022-07-08 |
| Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR (NCT05635045) | Columbia University | 2022-07-08 |
| Phase I/IIa Study for PM1032 in the Treatment of Patients With Advanced Solid Tumors (NCT05839106) | Biotheus Inc. | 2022-07-08 |
| A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes (NCT05333835) | Jiangsu HengRui Medicine Co., Ltd. | 2022-07-08 |
| Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC) (NCT05330429) | Gilead Sciences | 2022-07-08 |
| Acceptability of a New Paediatric Formulation of Hydroxycarbamide in Children With Sickle Cell Disease. (NCT05470270) | Theravia | 2022-07-08 |
| Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer (NCT05113537) | Vadim S Koshkin | 2022-07-08 |
| A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS (NCT05448599) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2022-07-08 |
| Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (NCT05174169) | NRG Oncology | 2022-07-08 |
| Letermovir for the Prevention of CMV Infection in HSCT Recipients Based on the Outcome of mNGS (NCT06021210) | The First Affiliated Hospital of Soochow University | 2022-07-07 |
| Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients (NCT05758116) | Peking University Cancer Hospital & Institute | 2022-07-07 |
| THC Memory & Reward Learning Pilot (NCT05116527) | Hartford Hospital | 2022-07-07 |
| A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD) (NCT05166109) | ReveraGen BioPharma, Inc. | 2022-07-07 |
| Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder (NCT04982796) | Portland VA Research Foundation, Inc | 2022-07-07 |
| Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty (NCT05412992) | Teikoku Pharma USA, Inc. | 2022-07-07 |
| Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME) (NCT05282901) | Institut Curie | 2022-07-07 |
| Study of ARO-APOC3 in Adults With Dyslipidemia (NCT05413135) | Arrowhead Pharmaceuticals | 2022-07-07 |
| Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies (NCT05226871) | Pfizer | 2022-07-07 |
| A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors (NCT06245330) | Ascentawits Pharmaceuticals, Ltd | 2022-07-07 |
| Pembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC). (NCT05201612) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2022-07-07 |
| A Study to Evaluate Efficacy and Safety of GW117 Tablets in Major Depressive Disorder (NCT06796868) | Beijing Greatway Pharmaceutical Technology Co.,Ltd. | 2022-07-07 |
| A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder (NCT04919512) | Janssen Research & Development, LLC | 2022-07-07 |
| A Study of MK-1088 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-1088-002) (NCT05394350) | Merck Sharp & Dohme LLC | 2022-07-07 |
| KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia (NCT05421429) | Suzhou Alphamab Co., Ltd. | 2022-07-07 |
| Research Study Investigating How Well NDec Works in People With Sickle Cell Disease (NCT05405114) | Novo Nordisk A/S | 2022-07-07 |
| Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction (NCT05350969) | Cardior Pharmaceuticals GmbH | 2022-07-07 |
| A Study of TRK-950 in Patients With Advanced Solid Tumors (NCT05423262) | Toray Industries, Inc | 2022-07-06 |
| Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer (NCT05219435) | Spanish Oncology Genito-Urinary Group | 2022-07-06 |
| SV2A in Older Adults (NCT05465538) | Yale University | 2022-07-06 |
| Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older (NCT05373472) | CanSino Biologics Inc. | 2022-07-06 |
| ALSENLITE: Senolytics for Alzheimer's Disease (NCT04785300) | Mayo Clinic | 2022-07-06 |
| Docetaxel/Pembrolizumab in Head and Neck Squamous Cell Carcinoma (NCT05252429) | Hokkaido University Hospital | 2022-07-06 |
| Oregovomab and PLD in PARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment (NCT05407584) | Yonsei University | 2022-07-05 |
| TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals (NCT05275998) | TaiMed Biologics Inc. | 2022-07-05 |
| Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients. (NCT05389267) | Laboratoires Thea | 2022-07-05 |
| Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease (NCT05417126) | Nanoscope Therapeutics Inc. | 2022-07-05 |
| Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination (NCT05422508) | Green Cross Corporation | 2022-07-05 |
| Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study (NCT05128903) | St. Jude Children's Research Hospital | 2022-07-05 |
| Evaluation of Safety and Efficacy of Allo GDA-201 Natural Killer (NK) Cells in Patients With Relapsed/Refractory B Cell NHL (NCT05296525) | Gamida Cell ltd | 2022-07-05 |
| A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies (NCT05379634) | Janssen Research & Development, LLC | 2022-07-05 |
| SHOrt Course Radiation and TASOX (TAS102 Plus Oxaliplatin) Chemotherapy in Operable Rectal Cancer (NCT04417699) | Providence Health & Services | 2022-07-05 |
| A Study of MG-K10 in Subjects With Asthma (NCT05382910) | Shanghai Mabgeek Biotech.Co.Ltd | 2022-07-05 |
| Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia (NCT04982354) | Guenther Koehne | 2022-07-05 |
| SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer (NCT05300269) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-07-05 |
| A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia (NCT05227703) | AbbVie | 2022-07-05 |
| A Study to Evaluate the Effect of a Contraceptive Vaginal Ring LSP- 5415 on Ovarian Function in Healthy Adult Females (NCT05360550) | Lupin Research Inc | 2022-07-05 |
| Intensive Upper Limb Training in Chronic Stroke (NCT05527262) | University College, London | 2022-07-04 |
| Ketamine for Treatment-Resistant Bipolar Disorder (NCT05004896) | Joshua Rosenblat | 2022-07-04 |
| Evaluation of SclerFIX Graft in Scleral Thinning After Exeresis of Tumors of the Ocular Surface (NCT05302609) | TBF Genie Tissulaire | 2022-07-04 |
| A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas (NCT05415072) | Novartis Pharmaceuticals | 2022-07-04 |
| Patient-derived-organoid (PDO) Guided Versus Conventional Therapy for Advanced Inoperable Abdominal Tumors (NCT05378048) | Chinese University of Hong Kong | 2022-07-04 |
| Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT (NCT05628922) | Fudan University | 2022-07-02 |
| Sintilimab Combined With Chemotherapy and Radiotherapy in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Multicenter Study (NCT05417139) | Sun Yat-sen University | 2022-07-01 |
| Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer (NCT03872505) | Cedars-Sinai Medical Center | 2022-07-01 |
| rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19 (NCT05485584) | Sichuan Huiyang Life Science and Technology Corporation | 2022-07-01 |
| Vestibular Socket Therapy Using Acellular Dermal Matrix Versus Connective Tissue Graft (NCT06241196) | Tanta University | 2022-07-01 |
| A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer (NCT05101616) | Shanghai Minimally Invasive Surgery Center | 2022-07-01 |
| Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy (NCT05817201) | Taizhou Hospital | 2022-07-01 |
| Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-modifying Antirheumatic Drug(s) (bDMARDs) Treatment (NCT05165771) | Gilead Sciences | 2022-07-01 |
| Tislelizumab Plus Lenvatinib in Stage III-IV RCC (NCT05485883) | Tianjin Medical University Second Hospital | 2022-07-01 |
| Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy (NCT05451719) | Fudan University | 2022-07-01 |
| Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML (NCT06827899) | The First Affiliated Hospital of Xiamen University | 2022-07-01 |
| Hetrombopag for Lower-risk MDS With Thrombocytopenia: a Prospective，Open-label, Single-arm Study. (NCT05392647) | Tongji Hospital | 2022-07-01 |